Salivary gland epithelial cells (SGEC): Carriers of exquisite B7-2 (CD86) costimulatory molecules

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 188-191

  Kapsogeorgou, Efstathia K ^a   Manoussakis, Menelaos N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

B7 2 (CD86) alternate transcripts; B7 2 (CD86) costimulatory molecules; Salivary gland epithelial cells; Sj gren's syndrome

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; HETERODIMER; MESSENGER RNA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; DENDRITIC CELL; DIMERIZATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RNA SPLICING; SALIVARY GLAND; SALIVARY GLAND EPITHELIUM CELL; SJOEGREN SYNDROME;

ALTERNATIVE SPLICING; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD86; EPITHELIAL CELLS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION PROFILING; HUMANS; MODELS, IMMUNOLOGICAL; MONOCYTES; PROTEIN BINDING; PROTEIN ISOFORMS; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 77957778813     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.006     Document Type: Article

References (48)

1. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002, 20:29-53.
2. Fife B.T., Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 2008, 224:166-182.
3. Keir M.E., Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 2005, 204:128-143.
4. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258.
5. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252.
6. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126.
7. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu Rev Immunol 2005, 23:515-548.
8. Seliger B., Marincola F.M., Ferrone S., Abken H. The complex role of B7 molecules in tumor immunology. Trends Mol Med 2008, 14:550-559.
9. Bhatia S., Edidin M., Almo S.C., Nathenson S.G. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett 2006, 104:70-75.
10. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997, 6:303-313.
11. Sansom D.M., Manzotti C.N., Zheng Y. What's the difference between CD80 and CD86?. Trends Immunol 2003, 24:314-319.
12. Suvas S., Singh V., Sahdev S., Vohra H., Agrewala J.N. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002, 277:7766-7775.
13. Collins A.V., Brodie D.W., Gilbert R.J., Iaboni A., Manso-Sancho R., Walse B., et al. The interaction properties of costimulatory molecules revisited. Immunity 2002, 17:201-210.
14. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001, 410:604-608.
15. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001, 410:608-611.
16. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994, 1:793-801.
17. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., Allison J.P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
18. Judge T.A., Wu Z., Zheng X.G., Sharpe A.H., Sayegh M.H., Turka L.A. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999, 162:1947-1951.
19. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995, 181:1145-1155.
20. Liang B., Gee R.J., Kashgarian M.J., Sharpe A.H., Mamula M.J. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. J Immunol 1999, 163:2322-2329.
21. Archimandritis A., Sougioultzis S., Foukas P.G., Tzivras M., Davaris P., Moutsopoulos H.M. Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. Clin Exp Immunol 2000, 119:464-471.
22. Lozanoska-Ochser B., Klein N.J., Huang G.C., Alvarez R.A., Peakman M. Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration. J Immunol 2008, 181:6109-6116.
23. Murata K., Dalakas M.C. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999, 155:453-460.
24. Nakazawa A., Watanabe M., Kanai T., Yajima T., Yamazaki M., Ogata H., et al. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. Gastroenterology 1999, 117:536-545.
25. Niemann-Masanek U., Mueller A., Yard B.A., Waldherr R., van der Woude F.J. B7-1 (CD80) and B7-2 (CD 86) expression in human tubular epithelial cells in vivo and in vitro. Nephron 2002, 92:542-556.
26. Seko Y., Takahashi N., Ishiyama S., Nishikawa T., Kasajima T., Hiroe M., et al. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 1998, 97:637-639.
27. Wu Q., Jinde K., Endoh M., Sakai H. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis 2003, 41:950-961.
28. Ye G., Barrera C., Fan X., Gourley W.K., Crowe S.E., Ernst P.B., et al. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J Clin Invest 1997, 99:1628-1636.
29. Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 2001, 166:3107-3113.
30. Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. A novel B7-2 (CD86) splice variant with a putative negative regulatory role. J Immunol 2008, 180:3815-3823.
31. Manoussakis M.N., Dimitriou I.D., Kapsogeorgou E.K., Xanthou G., Paikos S., Polihronis M., et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum 1999, 42:229-239.
32. Jellis C.L., Wang S.S., Rennert P., Borriello F., Sharpe A.H., Green N.R., et al. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics 1995, 42:85-89.
33. Fernandez-Ruiz E., Somoza C., Sanchez-Madrid F., Lanier L.L. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. Eur J Immunol 1995, 25:1453-1456.
34. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993, 366:76-79.
35. Freeman G.J., Gribben J.G., Boussiotis V.A., Ng J.W., Restivo V.A., Lombard L.A., et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993, 262:909-911.
36. Jeannin P., Magistrelli G., Aubry J.P., Caron G., Gauchat J.F., Renno T., et al. Soluble CD86 is a costimulatory molecule for human T lymphocytes. Immunity 2000, 13:303-312.
37. Hollsberg P., Scholz C., Anderson D.E., Greenfield E.A., Kuchroo V.K., Freeman G.J., et al. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J Immunol 1997, 159:4799-4805.
38. Manoussakis M.N., Kapsogeorgou E.K. The role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 2007, 32:225-230.
39. Borriello F., Oliveros J., Freeman G.J., Nadler L.M., Sharpe A.H. Differential expression of alternate mB7-2 transcripts. J Immunol 1995, 155:5490-5497.
40. Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T., Yoshida R., et al. A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28. Blood 2002, 99:2138-2145.
41. Inobe M., Aoki N., Linsley P.S., Ledbetter J.A., Abe R., Murakami M., et al. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. J Immunol 1996, 157:582-588.
42. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
43. Vijayakrishnan L., Slavik J.M., Illes Z., Greenwald R.J., Rainbow D., Greve B., et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 2004, 20:563-575.
44. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome. J Autoimmun 2010.
45. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
46. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
47. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
48. Gershwin M.E. The mosaic of autoimmunity. Autoimmun Rev 2008, 7:161-163.